CMHC Home
Program Menu
Accreditation
Credit Instructions
Faculty Bios
Faculty Disclosures
Supporters
Edit Profile
Contact Us
Stay Connected
with the CMHC
Facebook CMHC Twitter LinkedIn
 
 

 

 

 

Did you miss the Cardiometabolic Health Congress?

View selected presentations from the congress online and earn CME credits. Choose one of the programs below to begin. *Please Note: Registration is required to claim CME credit for online educational activities prior to viewing the activities.

1
State-of-the-Art Antiplatelet Therapy for Patients with ACS: Expert Analysis & Evidence-Based Guidelines for Optimizing Patient Outcomes
Supported by an educational grant from AstraZeneca
2 New Strategies for Obesity Management & Cardiometabolic Risk Reduction:
Expert Perspectives on Novel Therapies Targeting the CNS

Supported by an educational grant from Eisai, Inc.
spacer
3 Triglyceride & Mixed Dyslipidemia Management: Expert Analysis of
Cutting-Edge Data & Evidence-Based Recommendations for Reducing
Residual CV Risk

Supported by an educational grant from
Amarin Pharma, Inc.
4 Alternate Pathways for the Management of Type 2 Diabetes: Expert Analysis on Targeting Dopamine & the CNS for Glycemic Control & CV Risk Reduction
Supported by an educational grant from Santarus, Inc.
spacer
5 Personalized SIHD Management:
Evidence-Based Decision Making for Patients at Increased Cardiometabolic Risk

Supported by an independent educational grant from Gilead Sciences, Inc.
6 The Next-Generation of Weight-Loss Medications: Expert Recommendations for Managing Obesity, Diabetes & Cardiometabolic Risk
Supported by an educational grant from VIVUS, Inc.
spacer
7 Personalized T2DM Management:
The Role of Incretin Therapies Along the Continuum of Care

This activity is supported by an independent medical education grant from Bristol-Myers Squibb and AstraZeneca, LP
8 Next-Generation Vasodilating Beta Blockers Along the HTN Continuum of Care: Expert Recommendations for Targeting Endothelial Dysfunction, BP, and Cardiometabolic Risk
Supported by an educational grant from
Forest Laboratories, Inc.
spacer
9 State-of-the-Art Management of Severe and Familial Hypercholesterolemia:
Examining the Role of Antisense Therapy
in Clinical Practice

Supported by an educational grant from
Genzyme, A SANOFI COMPANY
10 Advances in Basal Insulin Therapy:
Expert Analysis of Novel Formulations, Combination Therapies & Delivery Technologies

Supported by an educational grant from
Novo Nordisk, Inc.
spacer
11 Getting to the Heart of Diabetic Dyslipidemia in High-Risk Patients:
Clinical Dilemmas & Novel Approaches to Cardiovascular Risk Reduction

Supported by an educational grant from
Genentech, A Member of the Roche Group
12 Obesity Management 2013:
Expert Perspectives on the Clinical Impact of Novel & Emerging Therapies

Supported by an educational grant from
Novo Nordisk, Inc
spacer
13 CV Outcomes for Oral & Incretin-Based Therapies: Examining Cutting-Edge Data & Clinical Implications for Patient Care
This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region
14 State-of-the-Art Advances in T2DM Management: Expert Analysis of New & Emerging GLP-1 Receptor Agonists
Supported by an educational grant from Lilly USA, LLC
spacer
 
© Cardiometabolic Health Congress Home  |  Program Menu  |  Accreditation  |  Credit Instructions  |  Faculty Bios  |  Faculty Disclosures  |  Supporters  |  Edit Profile  |  Contact Us